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TRAIL is a member of the TNF family of cytokines that influences many functions 
including cell death, immune response and inflammation1. In a previous study on cul-
tured HUVEC we demonstrated that TRAIL is able to activate eNOS and to increase 
NO release and prostanoid production1 that play a crucial role in endothelial cells func-
tion2. Since hyperglycaemia can result in endothelial injury, due to a decreased bioavail-
ability of NO3, we investigated the effects of TRAIL and nitric oxide synthase/nitric 
oxide (NOS/NO) related pathways on the endothelial cells function in umbilical cords 
derived from Gestational Diabetic women, as a model of chronic in vivo exposure to 
hyperglycaemia in humans. The expression of sTRAIL and TRAIL-Rs was evaluated 
on paraffin-embedded sections of umbilical cords obtained from 10 healthy pregnant 
women (controls) and 10 women affected with GD as well as on mononuclear cells puri-
fied from PBMC of 6 controls and 6 GD women. The labelling for sTRAIL, TRAIL-R1 
and TRAIL-R2 was found significantly higher in GD umbilical cords (venous endothe-
lial layer) as compared with controls (p<0.05). Interestingly, cytofluorimetric analysis of 
mononuclear cells showed an up-regulation of TRAIL-R2 (p<0.05) and sTRAIL as well 
as a down-regulation of TRAIL-R3 (p<0.05) in GD women. In parallel experiments, a 
more intense positivity of eNOS and nitrotyrosine labelling was observed in GD umbili-
cal cords (venous endothelial layer) as compared with control women. In addition, in 
vitro experiments, performed on cultured HUVEC derived from 4 GD umbilical cords 
and 4 healthy controls, displayed a significant increase in early apoptotic cells (Annexin 
V positive) in GD women (30.3%+10.8 vs 21.1%+5.0, p<0.001) after 1 h treatment with 
1000 ng/mL TRAIL. Our study shows that chronic hyperglycaemia induces eNOS ex-
pression and increases protein nitrosylation, suggesting that under these conditions 
most of the NO synthesized in excess is converted into peroxynitrite. In light of both 
ex vivo and in vitro observations, we may hypothesize a role for the TRAIL/TRAIL-R 
system in this model. 
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